Sort   by:  
 Page size 
TranscriptomicsAnkyrin-3 as a Molecular Marker of Early Life Stress and Vulnerability to Psychiatric Disorders
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
ORGANISM(S): Rattus norvegicus 
2016-07-06 | E-GEOD-84028 | biostudies-arrayexpress
UnknownInternational Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.
Not available
S-EPMC2847090 | biostudies-literature
UnknownProtein-altering germline mutations implicate novel genes related to lung cancer development.
Not available
S-EPMC7214407 | biostudies-literature
UnknownEarly Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial.
Not available
S-EPMC11519785 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
UnknownEffect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8491132 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownArrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
Not available
S-EPMC10487377 | biostudies-literature
UnknownPercutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial.
Not available
S-EPMC10782932 | biostudies-literature
Sort   by:  
 Page size